Posts

Showing posts from June, 2018

Impact of Racial Differences in Alzheimer Biomarkers

Image
Cerebral impairment in older African Americans is related with smaller changes in cerebrospinal fluid (CSF) tau biomarkers but greater influence from white matter hyperintensity (WMH) burden compared with impairment in older white Americans, according to a study from Emory University in Atlanta, Georgia. These race-associated variance in CSF tau markers may result in underdiagnosis of Alzheimer disease (AD) in African Americans, according to the researchers. This is the primary research to directly look at race, CSF AD biomarker levels, and the relationships between WMH and cognition.       Background The research team noted that the occurrence of AD is nearly doubled in African Americans compared with whites. Although African Americans also reportedly are more likely than whites to have nonamnestic forms of mild cognitive impairment (MCI) and slower decay to and through dementia, postmortem studies show that they have greater ischemia, which...

Building a Better World without Disorders

Image
We take immense pleasure in inviting all the participants from all over the world to attend the Neuroscience conference entitled “5 th  Annual Conference on  Stroke and Neurological disorders  ” to be held on November 12-13, 2018 in Istanbul, Turkey Stroke Meet 2018  has been planning and aiming to stimulate new techniques for treatment of Stroke and Neurological disorders that would be beneficial for the neurosurgery and other neurological issues. The conference will be coordinated around the theme ‘ Building a Better World without Disorders’ . Our goal is to bring together worldwide distinguished academics in the field of Neurology and Brain to exchange and share meaningful experiences of various treatment procedures for Neurological disorders  and Stroke.